KIT and neoplasm: Of note, BGJ398 used alone exhibited minor anti-tumor effects on IM-resistant xenografts (Figure 6B), thereby suggesting the activation of FGF-signaling as a compensatory mechanism of IM resistance in KIT-inhibited GISTs in vivo.